-
G125955-500mgGalanthamine is a long-acting, centrally active acetylcholinesterase(AChE) inhibitor (IC50 = 410 nM) and allosteric potentiator at neuronal nicotinic ACh receptors. A selective acetylcholinesterase inhibitor.
-
G610472-25mgGalapagos MAPKAPK5 inhibitor D.
-
G610472-5mgGalapagos MAPKAPK5 inhibitor D.
-
T127853-100mgTOK-001 (VN/124-1: Galeterone) is a multifunctional antiandrogen and CYP17 inhibitor(IC50=47 nM) in castration resistant prostate cancer (CRPC).An antagonist to LNCaP AR.
-
T127853-25mgTOK-001 (VN/124-1: Galeterone) is a multifunctional antiandrogen and CYP17 inhibitor(IC50=47 nM) in castration resistant prostate cancer (CRPC).An antagonist to LNCaP AR.
-
T127853-5mgTOK-001 (VN/124-1: Galeterone) is a multifunctional antiandrogen and CYP17 inhibitor(IC50=47 nM) in castration resistant prostate cancer (CRPC).An antagonist to LNCaP AR.
-
-
-
G129967-1gGallamine Triethiodide is a cholinergic receptor blocker with an IC50 of 68.0 ± 8.4 μM.Gallamine Triethiodide is a synthetic nondepolarizing blocking drug. Target: mAChR Gallamine triethiodide is a non-depolarising muscle relaxant. It acts by
-
G129967-250mgGallamine Triethiodide is a cholinergic receptor blocker with an IC50 of 68.0 ± 8.4 μM.Gallamine Triethiodide is a synthetic nondepolarizing blocking drug. Target: mAChR Gallamine triethiodide is a non-depolarising muscle relaxant. It acts by
-
G129967-25gGallamine Triethiodide is a cholinergic receptor blocker with an IC50 of 68.0 ± 8.4 μM.Gallamine Triethiodide is a synthetic nondepolarizing blocking drug. Target: mAChR Gallamine triethiodide is a non-depolarising muscle relaxant. It acts by
-
G129967-50mgGallamine Triethiodide is a cholinergic receptor blocker with an IC50 of 68.0 ± 8.4 μM.Gallamine Triethiodide is a synthetic nondepolarizing blocking drug. Target: mAChR Gallamine triethiodide is a non-depolarising muscle relaxant. It acts by